期刊文献+

大豆苷元对压力负荷性大鼠肾脏保护作用研究

Protective effects of daidzein on abdominal coarctation of the aorta in rats induced by pressure overload
下载PDF
导出
摘要 目的:研究大豆苷元(daidzein,DD)对压力负荷性实验大鼠肾脏的保护作用及其机制。方法:采用腹主动脉缩窄法制备大鼠实验模型。ig治疗4WK后处死大鼠,分别检测大鼠血浆及肾脏组织中血管紧张素Ⅱ(AngⅡ)含量、肾脏组织中肾素活性(RA)、一氧化氮(NO)、丙二醛(MDA)含量和超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-PX)、钙调神经磷酸酶(CaN)活性。结果:模型组大鼠血浆及肾组织AngⅡ含量明显增高,肾组织RA、MDA含量增高,CaN活性明显增高,肾组织NO含量、SOD、GSH-Px活力显著降低。与模型组比较,DD能显著提高肾组织NO含量,明显抑制血浆及肾组织AngⅡ的产生,降低肾组织RA、MDA含量及CaN的活性,提高肾组织SOD活力、GSH-Px酶活性。结论:DD对腹主动脉缩窄所致实验性大鼠肾脏有保护作用,可能与其清除氧自由基、升高NO含量、降低CaN活性、抑制AngⅡ产生有关。 Objective: To investigate the protective effects and mechanism of daidzein(DD) in rats induced by pressure overload. Methods: abdominal coarctation of the aorta model of rats induced by pressure overload was prepared by constricting abdominal aorta. The operated rats were randomly divided into sham operated control group ,aorta-constricted model group and three DD groups ( 30,60,120 mg/kg). Four weeks later, all rats were sacrificed and blood was collected by decapitated bleeding, in centrifuge tubes. The serum separated and the kidneys quickly harvested were measured the content of angiotensin Ⅱ respectively ,and the kidneys measured the activity of renin (RA) and the content of nitric oxide(NO) and the content of malondialdehyde (MDA) and superoxide dismutase (SOD) ,the activity of glutathione superoxide (GSH-PX) and calcineurin (CAN). Results: In model group, the content of Ang Ⅱ were significantly increased in the kidney and serum of rats ; the content of RA and MDA and the activity were markedly increased in kidney. The content of NO and the activity of SOD and GSH- Px were marked inhibited in kidney of model group. Compared with model group, the content of NO were significantly increased in kidney administrated DD group, and the product of Ang Ⅱ were suppressed, the content of RA and MDA and the activity of CaN were depressed.. The activity of SOD and GSH-Px in kidney was inhibited. Conclusion : DD has protective effects on kidney in rats induced by abdominal coaretation of the aorta and its mechanism may be related to raising NO content and reducing the level of Ang Ⅱ and the activity of CaN and cleansing oxygen free radical.
出处 《中药药理与临床》 CAS CSCD 北大核心 2008年第4期24-26,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 江西省卫生厅中医药管理处资助项目(No:2006A66) 江西省教育厅科技计划项目(GJJ08392)
关键词 大豆异黄酮 肾脏保护 一氧化氮 血管紧张素Ⅱ 钙调神经磷酸酶 daidzein kidney protection nitric oxide angiotension Ⅱ ealcineurin
  • 相关文献

参考文献11

  • 1Gibbons GH,Dzau VJ. The emerging concept of vascular remodeling . N Engl J Med, 1994;330(20): 1431 - 1438
  • 2陶霞,缪朝玉,陈红,苏定冯.去窦弓神经大鼠的胸主动脉重构[J].中国药理学通报,2001,17(1):44-47. 被引量:2
  • 3Fitzpatrick LA. Soy isoflavones : Hope or hype . Maturitas, 2003 ; (suppl): 21-29
  • 4Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as areplacement for traditionalestrogen replacement therapy . Archives Internal Medcine,2001 ;161 (9): 1161 - 1164
  • 5Anderson PG. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat . Circ Res, 1990 ;67 (6) : 943
  • 6Ruiz-Ortega M, Ruperez M, Esteban V, et al. Molecular mechanisms of angiotensin H-induced vascular injury. Curr Hypertens Rep,2003;5( 1 ): 73 ~ 79
  • 7Grainger DJ. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol, 2004;24(3): 399 ~404
  • 8Raij L. Workshop : Hypertension and cardiovascular risk factors : role of the angiotensin Ⅱ-nitric oxide interaction . Hypertension, 2001 ;37:767 - 773
  • 9陈雯,谢晓华,常连庆,孙愚,李朝晖,卢文宁,李晓玲,刘宁,刘秀华.醛固酮介导的肾性高血压相关靶器官组织钙调神经磷酸酶活性的变化[J].中国现代医学杂志,2004,14(17):58-61. 被引量:5
  • 10梁钢,黄志明,洪息君.儿茶素三种成分的抗氧化作用研究[J].广西医科大学学报,1998,15(1):9-11. 被引量:15

二级参考文献15

  • 1Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy[J], Cell, 1998, 93(2):215-228.
  • 2Bocs V, Abbott KL, Wang XF, et al. The cyclosporin A-sensitive nuclear factor of activated T cells(NFAT) proteins are expressed in vascular smooth muscle cells[J]. J Bio Chem, 1998, 273(31):19664-19671.
  • 3Shibasaki F, Mcken F. Calcineurin function in Ca2+ activated cell death in mammalian cells[J]. J Cell Biol,1995,131(3): 735-743.
  • 4Takeda Y, Yoneda Y, Demura M, et al. Calcinerin inhibition affenuates mineralocorticoid-induced cardiac hypertropgy[J]. Circulation, 2002, 12, 105(6): 677-679.
  • 5Qingxiang SU, Ming ZHAO, Elisabeth WEBER, et al. Distribution and activity of calcineurin in rat tissues Evidence for post-trancriptional regulation of testis-specific calcineurin B [J].Eur J Biochem, 1995, 230: 469-474.
  • 6Takeda Y, Yoneda T, Demura M, et al. Cardiac aldosterone production in genetically hypertentive rats [J]. Hypertention. 2000Oct,36(4): 495-500.
  • 7Young M,Fullerton M,Dilley R, et al. Mineralocorticoids,hypertension and cardiac fibrosis. J Clin Invest, 1994, 93:2578-2583.
  • 8Pasquale PD, Stefano GD, Paterna S. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies[J]. Ital Heart J, 2000 Sep, 1(9): 595-604.
  • 9龚侃,刘建国,程勇,刘建华,朱铨英,苏定冯.血压波动性增高引起的器官损伤[J].第二军医大学学报,1997,18(5):462-464. 被引量:23
  • 10吴平生,梁欣伟,戴云,刘宏,臧燕,郭志刚,张榕华,赖文岩,张远慧,刘伊丽.肾上腺外组织合成醛固酮[J].中华心血管病杂志,1998,26(2):139-141. 被引量:11

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部